Health Care/Hospital

iHerb officially launches an online activity named "good fortune shopping day" in the coming new year of ox

SINGAPORE, Feb. 8, 2021 /PRNewswire/ -- The year of the mouse rings out and the year of the ox rings in, and the Spring Festival of 2021 is drawing near soon. Through the epidemic haze in 2020, people value health much more and more. There's nothing better than giving our relatives and friends he...

2021-02-08 11:48 1804

Infinitus Mutual Help Organization Celebrates Its 10th Anniversary

GUANGZHOU, China, Feb. 8, 2021 /PRNewswire/ -- On January 31, 2021, a special exhibition celebrating the 10th anniversary of the founding of Infinitus Mutual Help Organization (Infinitus MHO) was held at Infinitus Xinhui Production Base in Jiangmen, Guangdong province. The goal of the six-month-l...

2021-02-08 09:00 1621

A Novel Drug-Device Combination Product Using Terumo's Automated Injection Device Completes Clinical Study in Japan

TOKYO, Feb. 8, 2021 /PRNewswire/ -- Terumo Corporation (TSE: 4543) today announced the completion of a clinical study inJapan for a product using Terumo's automated injection device developed in collaboration with Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin). Kyowa Kirin initiated the clinica...

2021-02-08 09:00 3075

Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab

SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the commencement of a proposed registered underwritten pu...

2021-02-06 06:27 9198

Hidrox(R), a proprietary olive polyphenols formulation may help in managing COVID-19 pandemic

HAYWARD, Calif., Feb. 6, 2021 /PRNewswire/ -- Oliphenol LLC, Hayward, California , announces the publication of a discovery focused upon the SARS-CoV-2-inactivating activity of Hidrox®, an olive polyphenols formulation for a potential treatment against SARS-CoV-2 infection. The Paper, "The SARS-C...

2021-02-06 00:17 2835

I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S.

SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics, today announced multiple clinical advancements for its proprieta...

2021-02-05 21:00 5593

111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services

SHANGHAI, Feb. 5, 2021 /PRNewswire/ -- On January 11, 2021, 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jilin Baiyi Doctor Group Management Co., Lt...

2021-02-05 19:00 5036

Thomson X Inks Strategic Partnership with Singapore-Based Startup Plano and Set Sights on Managing Myopia in Asia

SINGAPORE, Feb. 5, 2021 /PRNewswire/ -- Thomson X ("TX"), a wholly-owned subsidiary of SGX Mainboard-listed Thomson Medical Group Limited (the "Group"), today announced a strategic partnership with Plano Pte Ltd (" Plano"), a Singapore-based HealthTech startup. The collaboration will leverage on ...

2021-02-05 18:00 3121

iHerb holds "Happy Lunar New Year" themed sales event

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- To add joy to every customer, iHerb officially open the theme of "Happy Lunar New Year!" with a considerable discount. Happy Lunar New Year! Discount: customers can get 8% discount only if the order full of ...

2021-02-05 17:34 3017

Report offers checkup on health of Chinese people in 2020

HANGZHOU, China, Feb. 5, 2021 /PRNewswire/ -- Over 60 percent of respondents held a positive attitude toward the prospects of China's healthcare system and the potential for technologies, a health report found. China Daily app and DX Doctor (DXY), a health information sharing platform, published...

2021-02-05 13:08 2357

TCAI physicians participate in clinical trial for potential life-saving device for patients with heart rhythm disorders

AUSTIN, Texas, Feb. 5, 2021 /PRNewswire/ -- Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation procedures safer for...

2021-02-05 12:20 2261

Sihuan Pharmaceutical (0460.HK) The sole agent of Letybo 100U China AI Listing Conference was successfully held

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- Exclusively represented by Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange stock code: 0460), Letybo®100U, a type A botuli...

2021-02-05 11:32 4527

Boao Lecheng: A Miraculous Pioneer of Asian High-end Medical Tourism

HAIKOU, China, Feb. 5, 2021 /PRNewswire/ -- Recently, Boao Super Hospital performed an operation of transcatheter aortic valve replacement (TAVR) in conjunction with the use of the TriGUARD3TM Cerebral Embolic Protection Device (hereafter referred to as TriGUARD3). This is the first clinical appl...

2021-02-05 10:36 1797

IHME extends COVID-19 forecasts to June 1, predicting over 3.5 million deaths globally

Rapid vaccination rollout, mask wearing crucial to control spread SEATTLE, Feb. 5, 2021 /PRNewswire/ -- The latest COVID-19 forecasts from the Institute for Health Metrics and Evaluation at theUniversity of Washington School of Medicine predict more than 3.5 million deaths globally byJune 1. Th...

2021-02-05 10:09 2422

DFI Joins Hands with German ACL to Develop Substantial Business Opportunities in the Smart Medical Market

TAIPEI, Feb. 5, 2021 /PRNewswire/ -- DFI, a leading industrial computer manufacturer, has entered a strategic alliance with ACL, a well-known German medical IT hardware manufacturer, and will combine with DFI's 40 years of rich experience in industrial computers. ACL has been famous in the medica...

2021-02-05 09:00 2221

Introducing geneslim (tm), a new weight management innovation combining latest nutritional science, body contouring technology and genetics research

HONG KONG, Feb. 5, 2021 /PRNewswire/ -- geneslimtm, a new weight and health management program backed by latest nutritional science and genetics research, helps to manage weight and increases vitality for busy Hong Kongers. gene...

2021-02-05 08:08 1875

Thousands Join Global Call for Universal Access to Reproductive Health at 'Not Without FP' Virtual Forum

International leaders and experts advocate for rights-based family planning, examine threat COVID-19 poses to reproductive health BALTIMORE, Feb. 5, 2021 /PRNewswire/ -- More than 7,000 people attended this week's global online forum, "Not Without FP," to champion the important role family plann...

2021-02-05 07:13 1818

Global survey presented at the Digital Liver Cancer Summit 2021 reveals heavy toll of COVID-19 first wave on liver cancer care

GENEVA, Feb. 5, 2021 /PRNewswire/ -- The delays of screening programmes, diagnostic imaging and biopsies, cuts in the numbers of physicians available to treat liver cancer patients, cancellations of surgery, and a drop in the number of patients entered on clinical trials, were just some of the is...

2021-02-05 07:00 2240

Ortho Clinical Diagnostics Announces Closing of Full Over-Allotment Option from Initial Public Offering

RARITAN, N.J., Feb. 5, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX) ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving lives through innovative laboratory testing and blood-typing solutions, today announced the cl...

2021-02-05 06:40 6599

I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China

SHANGHAI and GAITHERSBURG, Md., Feb. 4, 2021 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed in a phase 2 clinic...

2021-02-04 21:00 5008
1 ... 560561562563564565566 ... 808